Abstract

Human serum albumin (HSA) is an important biomarker for chronic kidney disease, cardiovascular disease, and liver disease, yet its measurement is subject to the routine clinical laboratories. Pioneering studies have demonstrated that few of the ratiometric fluorescent probes enable the point-of-care (POC) testing of HSA with the aid of affordable domestic apparatuses. Still, the lack of choices of fluorophores restricts the development of such assay. In the present work, we propose two design strategies on the typical donor-acceptor fluorescent probe via the structural engineering. The results suggest that replacement of the dimethylamino group in probe by the weaker electron donating thiophene group can effectively tune the fluorescence response to HSA from off-on to ratiometric, ideally suiting for the POC application. The screened fluorescent probe is capable of detecting HSA with the features of fast response (< 10 s), stable output, high sensitivity (limit of detection = 54 nM), tunable detection range, and great anti-interference. Moreover, the ratiometric fluorescence response to HSA can be recorded and analyzed by the portable miniaturized paper-based or 3D-printed devices at the point of need. The success of structural engineering in the present study provides an efficient way to rationally regulate the fluorescence response mode of the donor-acceptor probes.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.